Ignite Creation Date:
2025-12-24 @ 5:46 PM
Ignite Modification Date:
2026-01-02 @ 8:10 AM
Study NCT ID:
NCT00604968
Status:
TERMINATED
Last Update Posted:
2017-06-07
First Post:
2008-01-21
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pegylated Liposomal Doxorubicin (Caelyx(R)) as Monotherapy in Elderly Patients With Locally Advanced and/or Metastatic Breast Cancer (Study P05059)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-02-07
Start Date Type:
ACTUAL
Primary Completion Date:
2009-10-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-10-16
Completion Date Type:
ACTUAL
First Submit Date:
2008-01-21
First Submit QC Date:
None
Study First Post Date:
2008-01-30
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2011-01-27
Results First Submit QC Date:
None
Results First Post Date:
2011-05-02
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-05-15
Last Update Post Date:
2017-06-07
Last Update Post Date Type:
ACTUAL